Ims Health Newswire

Ims Health Newswire

Comprehensive Real-Time News Feed for Ims Health.

Results 1 - 20 of 50 in Ims Health

  1. Valeant and Biosyent: Opposites Don't AttractRead the original story w/Photo

    Thursday May 31 | GuruFocus.com

    " To be nobody-but-yourself - in a world which is doing its best, night and day, to make you everybody else - means to fight the hardest battle which any human being can fight ." Recently someone sent me a copy of my 2016 presentation at the GuruFocus conference and had some questions about my comments on Valeant .

    Comment?

  2. BioSyent (RX) Set to Announce Quarterly Earnings on WednesdayRead the original story w/Photo

    Sunday May 27 | Daily Political

    BioSyent will post its quarterly earnings results after the market closes on Wednesday, May 30th. Analysts expect BioSyent to post earnings of C$0.07 per share for the quarter.

    Comment?

  3. BioSyent (RX) to Release Quarterly Earnings on WednesdayRead the original story w/Photo

    Wednesday May 23 | AmericanBankingNews.com

    BioSyent is scheduled to announce its earnings results after the market closes on Wednesday, May 30th. Analysts expect the company to announce earnings of C$0.07 per share for the quarter.

    Comment?

  4. CVE-2017-18142 (mdm9650_firmware, mdm9655_firmware, sd_835_firmware,...Read the original story

    Apr 11, 2018 | National Vulnerability Database

    In Android before security patch level 2018-04-05 on Qualcomm Snapdragon Mobile MDM9650, MDM9655, SD 835, SD 845, SD 850, while processing the IMS SIP username, a buffer overflow can occur. In Android before security patch level 2018-04-05 on Qualcomm Snapdragon Mobile MDM9650, MDM9655, SD 835, SD 845, SD 850, while processing the IMS SIP username, a buffer overflow can occur.

    Comment?

  5. BioSyent Inc. (RX) Analysts See $0.07 EPS; Scopia Capital Management...Read the original story w/Photo

    May 6, 2018 | Hill Country Times

    BioSyent Inc. Analysts See $0.07 EPS; Scopia Capital Management LP Has Cut Spirit Aerosystems Hldgs Holding By $190.00 Million Scopia Capital Management Lp decreased Spirit Aerosystems Hldgs Inc stake by 27.39% reported in 2017Q4 SEC filing. Scopia Capital Management Lp sold 2.18 million shares as Spirit Aerosystems Hldgs Inc 's stock declined 3.86%.

    Comment?

  6. IMS Health (IMS) Earns Media Impact Rating of 0.22Read the original story w/Photo

    May 4, 2018 | IntersportsWire

    Headlines about IMS Health have trended somewhat positive on Friday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million news and blog sources.

    Comment?

  7. Ubuntu 3619-2: Linux kernel (Xenial HWE) vulnerabilitiesRead the original story

    Apr 5, 2018 | LinuxSecurity.com

    Software Description: - linux-aws: Linux kernel for Amazon Web Services systems - linux-lts-xenial: Linux hardware enablement kernel from Xenial for Trusty Details: USN-3619-1 fixed vulnerabilities in the Linux kernel for Ubuntu 16.04 LTS. This update provides the corresponding updates for the Linux Hardware Enablement kernel from Ubuntu 16.04 LTS for Ubuntu 14.04 LTS.

    Comment?

  8. Ubuntu 3617-3: Linux kernel (Raspberry Pi 2) vulnerabilitiesRead the original story

    Apr 4, 2018 | LinuxSecurity.com

    Software Description: - linux-raspi2: Linux kernel for Raspberry Pi 2 Details: It was discovered that a race condition leading to a use-after-free vulnerability existed in the ALSA PCM subsystem of the Linux kernel. A local attacker could use this to cause a denial of service or possibly execute arbitrary code.

    Comment?

  9. Ubuntu 3619-1: Linux kernel vulnerabilitiesRead the original story

    Apr 4, 2018 | LinuxSecurity.com

    Software Description: - linux: Linux kernel - linux-aws: Linux kernel for Amazon Web Services systems - linux-kvm: Linux kernel for cloud environments - linux-raspi2: Linux kernel for Raspberry Pi 2 - linux-snapdragon: Linux kernel for Snapdragon processors Details: Jann Horn discovered that the Berkeley Packet Filter implementation in the Linux kernel improperly performed sign extension in some situations. A local attacker could use this to cause a denial of service or possibly execute arbitrary code.

    Comment?

  10. Ubuntu 3617-1: Linux kernel vulnerabilitiesRead the original story

    Apr 3, 2018 | LinuxSecurity.com

    Software Description: - linux: Linux kernel Details: It was discovered that a race condition leading to a use-after-free vulnerability existed in the ALSA PCM subsystem of the Linux kernel. A local attacker could use this to cause a denial of service or possibly execute arbitrary code.

    Comment?

  11. Ubuntu 3617-2: Linux (HWE) vulnerabilitiesRead the original story

    Apr 3, 2018 | LinuxSecurity.com

    Software Description: - linux-gcp: Linux kernel for Google Cloud Platform systems - linux-hwe: Linux hardware enablement kernel - linux-oem: Linux kernel for OEM processors Details: USN-3617-1 fixed vulnerabilities in the Linux kernel for Ubuntu 17.10. This update provides the corresponding updates for the Linux Hardware Enablement kernel from Ubuntu 17.10 for Ubuntu 16.04 LTS.

    Comment?

  12. Dr. Reddy's Laboratories Announces the Launch of Palonosetron...Read the original story

    Mar 25, 2018 | Customer Interaction Solutions

    Dr. Reddy's Laboratories Ltd. announced today that it has launched Palonosetron Hydrochloride Injection, 0.25 mg / 5 mL, a therapeutic equivalent generic version of ALOXI Injection approved by the U.S. Food and Drug Administration . The ALOXI brand and generic had U.S. sales of approximately $446 million MAT for the most recent twelve months ending in January 2018 according to IMS Health*.

    Comment?

  13. Biosyent (RX) Receives "Accumulate" Rating from Bloom BurtonRead the original story w/Photo

    Mar 24, 2018 | AmericanBankingNews.com

    's stock had its "accumulate" rating reaffirmed by investment analysts at Bloom Burton in a research report issued to clients and investors on Thursday. Shares of Biosyent stock opened at C$9.80 on Thursday.

    Comment?

  14. Bloom Burton Reiterates Accumulate Rating for BiosyentRead the original story w/Photo

    Mar 24, 2018 | IntersportsWire

    's stock had its "accumulate" rating restated by equities research analysts at Bloom Burton in a note issued to investors on Thursday. Shares of Biosyent stock opened at C$9.80 on Thursday.

    Comment?

  15. Biosyent (RX) Releases Earnings Results, Hits ExpectationsRead the original story w/Photo

    Mar 23, 2018 | Daily Political

    Biosyent released its earnings results on Wednesday. The company reported C$0.10 earnings per share for the quarter, meeting the Zacks' consensus estimate of C$0.10, Morningstar.com reports.

    Comment?

  16. IQVIA announces increased revenueRead the original story w/Photo

    Feb 14, 2018 | Connecticut Post

    IQVIA, which provides data to the health care industry, was formed by the merger of IMS Health and Quntiles in October 2016. It changed its name from QuintilesIMS to IQVIA in the fall of 2017.

    Comment?

  17. Dr. Reddy's Laboratories Announces the Launch of Tetrabenazine Tablets in the U.S. MarketRead the original story

    Feb 2, 2018 | Customer Interaction Solutions

    Dr. Reddy's Laboratories Ltd announced today that it has launched Tetrabenazine Tablets, a therapeutic equivalent generic version of Xenazine in the United States market approved by the U.S. Food and Drug Administration . The Xenazine brand and generic had U.S. sales of approximately $322 million MAT for the most recent twelve months ending in November 2017 according to IMS Health*.

    Comment?

  18. Burger King, Net Neutrality, and Commercial SpeechRead the original story

    Jan 31, 2018 | PrawfsBlawg

    ... this look like core speech. In light of the Court's more recent decisions on commercial speech (e.g., Sorrell v. IMS Health Inc. ), I believe BK's ad would be treated as noncommercial, but I would love to hear what others think.

    Comment?

  19. Federated Investors, Inc. (FII) Reaches $35.30 After 6.00% Up Move;...Read the original story

    Jan 17, 2018 | Hill Country Times

    Federated Investors, Inc. Reaches $35.30 After 6.00% Up Move; Aetna New Shorts Lowered By 8.2% The stock of Federated Investors, Inc. is a huge mover today! The stock increased 2.14% or $0.74 during the last trading session, reaching $35.3. About 351,699 shares traded. Federated Investors, Inc. has declined 14.01% since January 17, 2017 and is downtrending.

    Comment?

  20. Dr. Reddy's Laboratories announces the launch of Melphalan...Read the original story

    Dec 26, 2017 | Customer Interaction Solutions

    Dr. Reddy's Laboratories Ltd announced today that it has launched Melphalan Hydrochloride for Injection, a therapeutic equivalent generic version of Alkeran for Injection in the United States market approved by the U.S. Food and Drug Administration . The Alkeran brand and generic had U.S. sales of approximately $107 million MAT for the most recent twelve months ending in October 2017 according to IMS Health*.

    Comment?